07/14/2025
3:12 PM | NAP PoolCo B.V. (Reporting)
NewAmsterdam Pharma (Subject)
NewAmsterdam Pharma Co N.V. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/11/2025
3:25 PM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/26/2025
6:41 PM | NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Topper James N (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2025
3:42 PM | NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Topper James N (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2025
3:50 PM | Kling Douglas F (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2025
11:31 AM | NAP PoolCo B.V. (Reporting)
NewAmsterdam Pharma (Subject)
NewAmsterdam Pharma Co N.V. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/11/2025
8:00 AM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/09/2025
6:28 AM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/06/2025
3:35 PM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2025
3:40 PM | Kling Douglas F (Reporting)
NewAmsterdam Pharma (Subject)
NewAmsterdam Pharma Co N.V. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/13/2025
10:44 AM | Capital World Investors (Filed by)
NewAmsterdam Pharma (Subject)
NewAmsterdam Pharma Co N.V. (Subject)
| Form SCHEDULE 13G | |
Get the Latest News and Ratings for NAMS and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for NewAmsterdam Pharma and its competitors with MarketBeat's FREE daily newsletter. |
05/08/2025
3:28 PM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form ARS | |
05/08/2025
7:00 AM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/08/2025
7:00 AM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/07/2025
6:36 AM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/21/2025
4:41 PM | LANGE LOUIS G (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/17/2025
4:34 PM | Gulfo Adele M. (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/17/2025
4:36 PM | Gulfo Adele M. (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/17/2025
4:41 PM | Kling Douglas F (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/17/2025
4:06 PM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/28/2025
4:36 PM | NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Topper James N (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/28/2025
4:18 PM | Kling Douglas F (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/28/2025
4:20 PM | Kastelein Johannes Jacob Pieter (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/28/2025
4:24 PM | LANGE LOUIS G (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/28/2025
4:29 PM | Kooij Louise Frederika (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/26/2025
5:19 PM | Davidson Michael H. (Reporting)
NewAmsterdam Pharma (Subject)
NewAmsterdam Pharma Co N.V. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/26/2025
5:00 PM | Kling Douglas F (Reporting)
NewAmsterdam Pharma (Subject)
NewAmsterdam Pharma Co N.V. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/26/2025
3:27 PM | Kastelein Johannes Jacob Pieter (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2025
4:29 PM | Kling Douglas F (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/10/2025
11:15 PM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form EFFECT | |
03/10/2025
3:52 PM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form 424B3 | |
03/06/2025
4:32 PM | NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Topper James N (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2025
5:10 PM | Kooij Louise Frederika (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
5:54 PM | Kooij Louise Frederika (Reporting)
NewAmsterdam Pharma (Subject)
NewAmsterdam Pharma Co N.V. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/28/2025
4:06 PM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
02/26/2025
7:00 AM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/26/2025
7:00 AM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/20/2025
4:24 PM | Kling Douglas F (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2025
5:42 PM | NewAmsterdam Pharma (Subject)
NewAmsterdam Pharma Co N.V. (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SCHEDULE 13G/A | |
01/31/2025
4:00 PM | Kling Douglas F (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2025
4:25 PM | NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Somaiya Mayur Ian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Genesis 14:13-17 [HIDDEN MEANING?] (Ad) A mysterious Bible verse from Genesis may hold the key to unlocking what one expert calls an “American birthright” — a $150 trillion wealth vault that’s remained untouched for over a century.
Jim Rickards believes President Trump is about to unleash it — and investors who move first could come out on top. The full story is now available. Watch the presentation on America’s hidden birthright |
01/29/2025
4:16 PM | Kling Douglas F (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/27/2025
4:09 PM | Kling Douglas F (Reporting)
NewAmsterdam Pharma (Subject)
NewAmsterdam Pharma Co N.V. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/27/2025
3:52 PM | NewAmsterdam Pharma (Subject)
NewAmsterdam Pharma Co N.V. (Subject)
Somaiya Mayur Ian (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/10/2025
3:26 PM | NAP PoolCo B.V. (Reporting)
NewAmsterdam Pharma (Subject)
NewAmsterdam Pharma Co N.V. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/10/2025
7:27 AM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2025
4:58 PM | NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
van der Kamp Hilde Johanna (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
5:03 PM | Lewis William (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
5:08 PM | McKenna Mark C. (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
5:09 PM | NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Smither John W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
4:57 PM | LANGE LOUIS G (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2025
4:21 PM | Kastelein Johannes Jacob Pieter (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2025
4:21 PM | Davidson Michael H. (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2025
4:21 PM | Kooij Louise Frederika (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2025
4:08 PM | NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Somaiya Mayur Ian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2025
4:10 PM | Kling Douglas F (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2025
4:12 PM | JONES WILLIAM A JR (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2025
3:29 PM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
01/06/2025
4:57 PM | Kling Douglas F (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
4:48 PM | Kastelein Johannes Jacob Pieter (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
4:51 PM | JONES WILLIAM A JR (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
4:53 PM | NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Somaiya Mayur Ian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
4:54 PM | Audet Juliette Berangere (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
4:56 PM | Kooij Louise Frederika (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2025
3:15 PM | Forbion Capital Fund IV Cooperatief U.A. (Reporting)
Forbion Growth Management B.V. (Reporting)
Forbion Growth Opportunities Fund I Cooperatief U.A. (Reporting)
Forbion IV Management B.V. (Reporting)
ForGrowth NAP B.V. (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/30/2024
3:15 PM | Forbion Capital Fund IV Cooperatief U.A. (Reporting)
Forbion Growth Management B.V. (Reporting)
Forbion Growth Opportunities Fund I Cooperatief U.A. (Reporting)
Forbion IV Management B.V. (Reporting)
ForGrowth NAP B.V. (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2024
3:15 PM | Forbion Capital Fund IV Cooperatief U.A. (Reporting)
Forbion Growth Management B.V. (Reporting)
Forbion Growth Opportunities Fund I Cooperatief U.A. (Reporting)
Forbion IV Management B.V. (Reporting)
ForGrowth NAP B.V. (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2024
3:25 PM | Forbion Capital Fund IV Cooperatief U.A. (Reporting)
Forbion Growth Management B.V. (Reporting)
Forbion Growth Opportunities Fund I Cooperatief U.A. (Reporting)
Forbion IV Management B.V. (Reporting)
ForGrowth NAP B.V. (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2024
3:15 PM | Forbion Capital Fund IV Cooperatief U.A. (Reporting)
Forbion Growth Management B.V. (Reporting)
Forbion Growth Opportunities Fund I Cooperatief U.A. (Reporting)
Forbion IV Management B.V. (Reporting)
ForGrowth NAP B.V. (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
4:35 PM | BCLS II Investco, LP (Filed by)
NewAmsterdam Pharma (Subject)
NewAmsterdam Pharma Co N.V. (Subject)
| Form SC 13D/A | |
12/17/2024
4:05 PM | Bain Capital Life Sciences Fund II, L.P. (Reporting)
Bain Capital Life Sciences Fund III, L.P. (Reporting)
Bain Capital Life Sciences III General Partner, LLC (Reporting)
Bain Capital Life Sciences Investors II, LLC (Reporting)
Bain Capital Life Sciences Investors, LLC (Reporting)
BCIP Life Sciences Associates, LP (Reporting)
BCLS Fund III Investments GP, LLC (Reporting)
BCLS Fund III Investments, LP (Reporting)
BCLS II Investco , LLC (0001819101) (Reporting)
BCLS II Investco, LP (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
3:00 PM | Forbion Capital Fund IV Cooperatief U.A. (Filed by)
NewAmsterdam Pharma (Subject)
NewAmsterdam Pharma Co N.V. (Subject)
| Form SC 13D/A | |
12/17/2024
9:28 AM | Frazier Life Sciences X, L.P. (Filed by)
NewAmsterdam Pharma (Subject)
NewAmsterdam Pharma Co N.V. (Subject)
| Form SC 13D/A | |
12/16/2024
3:15 PM | Forbion Capital Fund IV Cooperatief U.A. (Reporting)
Forbion Growth Management B.V. (Reporting)
Forbion Growth Opportunities Fund I Cooperatief U.A. (Reporting)
Forbion IV Management B.V. (Reporting)
ForGrowth NAP B.V. (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2024
7:28 AM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/13/2024
5:33 AM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form 424B5 | |
12/12/2024
3:15 PM | Forbion Capital Fund IV Cooperatief U.A. (Reporting)
Forbion Growth Management B.V. (Reporting)
Forbion Growth Opportunities Fund I Cooperatief U.A. (Reporting)
Forbion IV Management B.V. (Reporting)
ForGrowth NAP B.V. (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2024
6:57 PM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form S-3MEF | |
12/10/2024
3:48 PM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form 424B5 | |
12/10/2024
6:24 AM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/20/2024
6:07 AM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/15/2024
3:29 PM | Forbion Capital Fund IV Cooperatief U.A. (Filed by)
NewAmsterdam Pharma (Subject)
NewAmsterdam Pharma Co N.V. (Subject)
| Form SC 13D/A | |
11/14/2024
4:46 PM | NewAmsterdam Pharma (Subject)
NewAmsterdam Pharma Co N.V. (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13G/A | |
11/06/2024
7:00 AM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/06/2024
7:00 AM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/28/2024
7:02 AM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form 20-F/A | |
10/18/2024
3:51 PM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/11/2024
4:01 PM | Davidson Michael H. (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/01/2024
4:23 PM | Kooij Louise Frederika (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/01/2024
4:12 PM | Kooij Louise Frederika (Reporting)
NewAmsterdam Pharma (Subject)
NewAmsterdam Pharma Co N.V. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/30/2024
4:22 PM | Audet Juliette Berangere (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Missed the Run So Far? This Is Your Second Chance (Ad) According to history, the final stretch of the crypto cycle is here — and this short window is where fortunes are made.
Inside The Crypto Code Workshop, two experts reveal how to get positioned early, lock in profits, and access their top altcoin picks before the crowd. All attendees receive $10 in free Bitcoin just for showing up. Join The Crypto Code Workshop + get $10 in Bitcoin for attending |
08/23/2024
3:20 PM | AMGEN INC (Filed by)
NewAmsterdam Pharma (Subject)
NewAmsterdam Pharma Co N.V. (Subject)
| Form SC 13G/A | |
08/22/2024
3:30 PM | Davidson Michael H. (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/12/2024
11:15 PM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form EFFECT | |
08/09/2024
4:21 PM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form 424B5 | |
08/09/2024
4:23 PM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/09/2024
4:24 PM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form POS AM | |
08/07/2024
7:00 AM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/07/2024
7:00 AM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/29/2024
7:30 AM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Free NAMS Stock Alerts